Growth Metrics

Tg Therapeutics (TGTX) Shares Outstanding: 2016-2025

Historic Shares Outstanding for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $158.8 million.

  • Tg Therapeutics' Shares Outstanding rose 1.82% to $158.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158.8 million, marking a year-over-year increase of 1.82%. This contributed to the annual value of $156.2 million for FY2024, which is 3.13% up from last year.
  • Per Tg Therapeutics' latest filing, its Shares Outstanding stood at $158.8 million for Q3 2025, which was down 0.02% from $158.8 million recorded in Q2 2025.
  • Tg Therapeutics' Shares Outstanding's 5-year high stood at $158.8 million during Q2 2025, with a 5-year trough of $141.5 million in Q1 2021.
  • For the 3-year period, Tg Therapeutics' Shares Outstanding averaged around $154.7 million, with its median value being $154.9 million (2024).
  • Data for Tg Therapeutics' Shares Outstanding shows a peak YoY climbed of 28.41% (in 2021) over the last 5 years.
  • Over the past 5 years, Tg Therapeutics' Shares Outstanding (Quarterly) stood at $143.3 million in 2021, then climbed by 2.19% to $146.4 million in 2022, then increased by 3.44% to $151.5 million in 2023, then grew by 3.13% to $156.2 million in 2024, then grew by 1.82% to $158.8 million in 2025.
  • Its Shares Outstanding stands at $158.8 million for Q3 2025, versus $158.8 million for Q2 2025 and $158.7 million for Q1 2025.